In a strategic approach to regulating the rapidly growing diagnostic sector, the state health department has made it mandated registration of all diagnostic labs under the Clinical Establishment Act (CEA) 2010. Despite repeated notifications at both
The Indian Pharma Market (IPM) created a conducive growth environment in 2025 for March at 9.3% YoY, which shows a remarkable recovery from the months gone by. Key growth drivers included Cipla...
Cipla made significant progress after obtaining USFDA permission for marketing its generic cancer drug. The USFDA granted Cipla authorization to introduce their paclitaxel protein-bound particles for injectable suspension (albumin-bound) under the br
The Drug Administration Department of Karnataka has withdrawn defective medications totaling Rs 24.3 lakh from the market as part of a campaign against subpar pharmaceuticals.
The USFDA has approved the cancer treatment medication Jobevne, which has allowed Biocon Biologics, the biosimilar division of Biocon, to increase its oncology portfolio.
In order to prevent the sales of unapproved or illegal medicines in Indian market, import registration and license have been made mandatory by The Central Drugs Standard Control Organization. On April 8, the apex drug regulatory agency of India...
Donald Trump's remarks threatening massive tariffs on all imports of pharmaceuticals led to a crash in the Indian pharmaceutical stocks. The news unsettled the Indian...
Lyka Labs Limited has revealed that it has received an Indian Patent for its unique product, Pregabalin Gel 8 percent, with patent protection lasting until 2043.
Industry leaders want the Indian government to undertake an entire impact and vulnerability study to identify the risk associated with importing...
AstraZeneca Pharma India Limited has received the authorization from the Central Drugs Standard Control Organization (CDSCO), Directorate General of Health Services, Government of India, to import and market Osimertinib Tablets 40 mg & 80 mg....